These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21920209)

  • 41. Comparison of sevoflurane with halothane in pediatric ambulatory anesthesia: an experience in Taiwan.
    Chong ZK; Jawan B; Poon YY; Lee JH
    Acta Anaesthesiol Sin; 1997 Mar; 35(1):21-4. PubMed ID: 9212477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrasting effects on halothane hepatotoxicity in the phenobarbital-hypoxia and triiodothyronine model: mechanistic implications.
    Uetrecht J; Wood AJ; Phythyon JM; Wood M
    Anesthesiology; 1983 Sep; 59(3):196-201. PubMed ID: 6881584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Halothane induced fulminant hepatic failure.
    Qureshi MA; Saeed F; Hussain T
    J Coll Physicians Surg Pak; 2007 Feb; 17(2):103-4. PubMed ID: 17288858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypersensitivity of laryngeal C-fibers induced by volatile anesthetics in young guinea pigs.
    Mutoh T; Tsubone H
    Am J Respir Crit Care Med; 2003 Feb; 167(4):557-62. PubMed ID: 12426231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Severe acute hepatitis after anesthesia with sevoflurane].
    Gonzalo Pascual V; Forner González A; Salvador E; Forns Benhart X; Miquel Morera R; Bruguera Cortada M
    Gastroenterol Hepatol; 2005; 28(6):361-2. PubMed ID: 15989819
    [No Abstract]   [Full Text] [Related]  

  • 46. Halothane: how should it be used in a developing country?
    Mahboobi N; Esmaeili S; Safari S; Habibollahi P; Dabbagh A; Alavian SM
    East Mediterr Health J; 2012 Feb; 18(2):159-64. PubMed ID: 22571093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatotoxicity of halogenated inhalational anesthetics studied in rats hepatocytes].
    Sameshima T
    Masui; 1994 Apr; 43(4):454-66. PubMed ID: 8189607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of volatile inhalational anesthetics on cerebral blood volume and oxygen status in children].
    Tsypin LE; Prokop'ev GG; Lazarev VV; Shchukin VV; Popova TG; Kochkin VS; Lin'kova TV; Chusov KP
    Anesteziol Reanimatol; 2007; (1):4-7. PubMed ID: 17460978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Halothane: the last word?
    Holzki J
    Paediatr Anaesth; 2001 Mar; 11(2):249-52. PubMed ID: 11240888
    [No Abstract]   [Full Text] [Related]  

  • 50. Exposure Assessment, Biological Monitoring, and Liver Function Tests of Operating Room Personnel Exposed to Halothane in Hamedan Hospitals, West of Iran.
    Bakhshaei MH; Bahrami A; Mirzakhani A; Mahjub H; Assari MJ
    J Res Health Sci; 2017 Nov; 17(4):e00397. PubMed ID: 29233951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effect of repeated sevoflurane anesthesia on hepatic function and immunological system].
    Sato E; Nagano K; Akasaka N; Manaka S; Tateda T
    Masui; 2003 Oct; 52(10):1062-5. PubMed ID: 14598668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sevoflurane and liver dysfunction].
    Fernández-Meré LA; Muñoz González F; Sopena Zubiria LA; Alvarez Blanco M
    Rev Esp Anestesiol Reanim; 2008 Mar; 55(3):184-5. PubMed ID: 18401994
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative toxicity of halothane, isoflurane, hypoxia, and phenobarbital induction in monolayer cultures of rat hepatocytes.
    Schieble TM; Costa AK; Heffel DF; Trudell JR
    Anesthesiology; 1988 Apr; 68(4):485-94. PubMed ID: 3354886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A mouse model of severe halothane hepatitis based on human risk factors.
    Dugan CM; MacDonald AE; Roth RA; Ganey PE
    J Pharmacol Exp Ther; 2010 May; 333(2):364-72. PubMed ID: 20124411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Demonstration of halothane-induced hepatic lipid peroxidation in rats by quantification of F2-isoprostanes.
    Awad JA; Horn JL; Roberts LJ; Franks JJ
    Anesthesiology; 1996 Apr; 84(4):910-6. PubMed ID: 8638846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity.
    Cousins MJ; Sharp JH; Gourlay GK; Adams JF; Haynes WD; Whitehead R
    Anaesth Intensive Care; 1979 Feb; 7(1):9-24. PubMed ID: 434454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Halothane anesthesia does not exacerbate hepatic dysfunction in cirrhotic rats.
    Maze M; Smith CM; Baden JM
    Anesthesiology; 1985 Jan; 62(1):1-5. PubMed ID: 3966663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Halothane induced hepatitis: case report.
    Otedo AE
    East Afr Med J; 2004 Oct; 81(10):538-9. PubMed ID: 15715133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of sevoflurane and halothane anesthesia on liver circulation and oxygen metabolism in the dog during hepatolobectomy.
    Yu BW; Matsumoto N
    J Anesth; 1997 Sep; 11(3):213-218. PubMed ID: 28921114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of anticonvulsant agents on halothane-induced liver injury in human subjects and experimental animals.
    Nomura F; Hatano H; Ohnishi K; Akikusa B; Okuda K
    Hepatology; 1986; 6(5):952-6. PubMed ID: 3093358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.